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Abstract
The veal calf industry urgently needs to reduce antimicrobial use (AMU). A huge challenge, since 
this industry holds major risk factors for disease (e.g. young age, commingling, transport stress). As a 
result, fear is that a rapid decrease would increase mortality and therefore hamper animal welfare. 
This study explored the relationship between AMU and mortality in two major veal calf companies 
(integrations). Total AMU and different classes, including critically import antibiotics, were added to 
the model. The secondary objective was to determine risk factors for mortality. A retrospective 
cohort study was performed on electronically collected antimicrobial consumption and mortality 
data from the largest Belgian veal practice in the period 2014-2016. A mixed linear model was built to 
identify factors associated with mortality. The data consisted of 76 production cycles from 29 
different farms managed by two integrations (1 and 2), covering 45.001 dairy veal calves. Average 
AMU was 30.1 defined daily doses for animals per year (DDDvet/year, Standard deviation (±) 10.4), 
and was significantly higher in integration 2 (35.9 DDDvet/year ± 9.3) compared to 1 (22.4 ± 5.7). In 
contrast, integration 2 had significantly lower mortality than integration 1 (2.3% ± 1.4 vs 4.1% ± 1.4). 
Analysis showed a positive association between AMU and mortality in production cycles of 
integration 1 and no association at all in integration 2. In the final multivariable model, the mortality 
risk increased with an increasing herd size and with the use of 3th/4th generation cephalosporins. 
Whereas mortality risk decreased with an increased use of long-acting macrolides. This study shows 
that at the current levels of total and critically important AMU in Belgian dairy veal calves, a 
decreasing use was not associated with increased mortality. In contrast, in the veal company with 
the lowest AMU, a positive association with mortality was observed. These data suggest that no 
welfare issue was induced so far and that selection of appropriate antimicrobial therapy by the 
veterinarian as well as Identification of the veal company as an influencer of AMU and mortality will 
be crucial to further rationally reduce AMU in veal calves.
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This study explored the relationship between AMD and mortality in two major veal calf companies 
(integrations). Total AMD and different classes, including critically import antibiotics, were added to 
the model. The secondary objective was to determine risk factors for mortality. A retrospective 
cohort study was performed on electronically collected antimicrobial consumption and mortality 
data from the largest Belgian veal practice in the period 2014-2016. A mixed linear model was built to 
identify factors associated with mortality. The data consisted of 76 production cycles from 29 
different farms managed by two integrations (1 and 2), covering 45.001 dairy veal calves. Average 
AMD was 30.1 defined daily doses for animals per year (DDDvet/year, Standard deviation (±) 10.4), 
and was significantly higher in integration 2 (35.9 DDDvet/year ± 9.3) compared to 1 (22.4 ± 5.7). In 
contrast, integration 2 had significantly lower mortality than integration 1 (2.3% + 1.4 vs 4.1% ± 1.4). 
Analysis showed a positive association between AMU and mortality in production cycles of 
integration 1 and no association at all in integration 2. In the final multivariable model, the mortality 
risk increased with an increasing herd size and with the use of 3th/4th generation cephalosporins. 
Whereas mortality risk decreased with an increased use of long-acting macrolides. This study shows 
that at the current levels of total and critically important AMU in Belgian dairy veal calves, a 
decreasing use was not associated with increased mortality. In contrast, in the veal company with 
the lowest AMU, a positive association with mortality was observed. These data suggest that no 
welfare issue was induced so far and that selection of appropriate antimicrobial therapy by the 
veterinarian as well as identification of the veal company as an influencer of AMU and mortality will 
be crucial to further rationally reduce AMU in veal calves.
53
HAF ©2013
Vol. V, No. 3S (2018) ISSN: 2283-3927
Ninth International Conference on Antimicrobial Agents In Veterinary Medicine (AAVM) - Rome, Italy, October 16-19, 2018
Int. ]. of Health, Animal Science and Food safety 5-3S (2018) 53
The relationship between antimicrobial use 
and herd level mortality as a welfare 
indicator in veal calves.
Jade Bokma1’*, Randy Boone2, Piet Deprez1, Bart Pardon1
1 Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, 
Ghent University, Merelbeke, Belgium, zVeterinary Practice Venhei, Ceelsebaan 
95, 2460, Kasterlee, Belgium
UNIVBRSirA DEGU STUDI Dl MII-ANO 
DI.PARTIMEKTO Dl SC1ENZE VETERINAIRE 
PER LA SA LUIT, LA PRODUZJON E ANIMALE 
E LA SiCURKZZA AUMENTARE
Abstract
The veai calf industry urgently needs to reduce antimicrobial use (AMU). A huge challenge, since 
this industry holds major risk factors for disease (e.g. young age, commingling, transport stress). As a 
resuit, fear is that a rapid decrease would increase mortality and therefore hamper animal welfare. 
This study explored the relationship between AMU and mortality in two major veal calf companies 
(integrations). Total AMU and different classes, including critically import antibiotics, were added to 
the model. The secondary objective was to determine risk factors for mortality. A retrospective 
cohort study was performed on electronically collected antimicrobial consumption and mortality 
data from the largest Belgian veal practice in the period 2014-2016. A mixed linear model was built to 
identify factors associated with mortality. The data consisted of 76 production cycles from 29 
different farms managed by two integrations (1 and 2), covering 45.001 dairy veal calves. Average 
AMU was 30.1 defined daily doses for animals per year (DDDvet/year, Standard deviation (±) 10.4), 
and was significantly higher in integration 2 (35.9 DDDvet/year ± 9.3) compared to 1 (22.4 ± 5.7). In 
contrast, integration 2 had significantly lower mortality than integration 1 (2.3% ± 1.4 vs 4.1% + 1.4). 
Analysis showed a positive association between AMU and mortality in production cycles of 
integration 1 and no association at all in integration 2. In the final multivariable model, the mortality 
risk increased with an increasing herd size and with the use of 3th/4th generation cephalosporins. 
Whereas mortality risk decreased with an increased use of long-acting macrolides. This study shows 
that at the current levels of total and critically important AMU in Belgian dairy veal calves, a 
decreasing use was not associated with increased mortality. In contrast, in the veal company with 
the lowest AMU, a positive association with mortality was observed. These data suggest that no 
welfare issue was induced so far and that selection of appropriate antimicrobial therapy by the 
veterinarian as well as identification of the veal company as an influencer of AMU and mortality will 
be crucial to further rationally reduce AMU in veal calves.
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